Biolife Solutions Inc NT 10-Q, filed May 11, 2023
Biolife Solutions Inc (BLFS)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR
For Period Ended: March 31, 2023
☐Transition Report on Form 10-K
☐Transition Report on Form 20-F
☐Transition Report on Form 11-K
☐Transition Report on Form 10-K
☐Transition Report on Form N-SAR
For the Transition Period Ended:
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
|
Full name of Registrant: |
BioLife Solutions, Inc. |
|
Address of principal executive office: City State and ZIP Code: |
3303 Monte Villa Parkway, Suite 310 Bothell, WA 98021 |
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
(a) |
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
|
☒ |
(b) |
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
(c) |
The accountant's statement or other exhibit required by Rule 12(b)-25(c) has been attached if applicable. |
PART III — NARRATIVE
State below in reasonable detail why the Form 10-Q could not be filed within the prescribed time period.
BioLife Solutions, Inc. (the "Company') is unable to file its Quarterly Report Form 10-Q for the three months ended March 31, 2023 within the prescribed time period without unreasonable effort or expense due to a miscommunication with the Company’s financial printer. The Form 10-Q was otherwise complete, executed, and ready to be filed with the Commission prior to the 5:30 p.m. EDT deadline. The Company will file its Quarterly Report on or before the fifth calendar day following the prescribed due date.
PART IV — OTHER INFORMATION
|
(1) |
Name and telephone number of person to contact in regard to this notification: |
|
Troy Wichterman |
(425) 402-1400 |
|
Name |
Telephone Number |
|
(2) |
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). |
☒ Yes ☐ No
|
(3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? |
☐ Yes ☒ No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
| BioLife Solutions, Inc. |
| (Name of Registrant as Specified in Charter) |
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: May 11, 2023 |
/s/ Troy Wichterman |
|
|
Troy Wichterman |
||
|
Chief Financial Officer |